vs
Energy Services of America CORP（ESOA）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
再鼎医药的季度营收约是Energy Services of America CORP的1.1倍（$127.1M vs $114.1M），再鼎医药同比增速更快（17.1% vs 13.4%），Energy Services of America CORP自由现金流更多（$16.8M vs $-26.7M），过去两年Energy Services of America CORP的营收复合增速更高（26.7% vs 20.8%）
美国能源服务公司是一家美国能源服务控股企业，旗下拥有多个油气田设备租赁及油气井服务品牌，在油气能源服务领域开展相关业务。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
ESOA vs ZLAB — 直观对比
营收规模更大
ZLAB
是对方的1.1倍
$114.1M
营收增速更快
ZLAB
高出3.7%
13.4%
自由现金流更多
ESOA
多$43.5M
$-26.7M
两年增速更快
ESOA
近两年复合增速
20.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $114.1M | $127.1M |
| 净利润 | — | — |
| 毛利率 | 12.3% | 51.0% |
| 营业利润率 | 4.3% | -54.6% |
| 净利率 | — | — |
| 营收同比 | 13.4% | 17.1% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.16 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESOAZLAB
| Q4 25 | $114.1M | $127.1M | ||
| Q3 25 | $130.1M | $115.4M | ||
| Q2 25 | $103.6M | $109.1M | ||
| Q1 25 | $76.7M | $105.7M | ||
| Q4 24 | $100.6M | $108.5M | ||
| Q3 24 | $104.7M | $101.8M | ||
| Q2 24 | $85.9M | $100.1M | ||
| Q1 24 | $71.1M | $87.1M |
净利润ESOAZLAB
| Q4 25 | — | — | ||
| Q3 25 | — | $-36.0M | ||
| Q2 25 | — | $-40.7M | ||
| Q1 25 | — | $-48.4M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-41.7M | ||
| Q2 24 | — | $-80.3M | ||
| Q1 24 | — | $-53.5M |
毛利率ESOAZLAB
| Q4 25 | 12.3% | 51.0% | ||
| Q3 25 | 12.6% | 59.5% | ||
| Q2 25 | 11.6% | 60.6% | ||
| Q1 25 | 0.1% | 63.6% | ||
| Q4 24 | 10.2% | 61.5% | ||
| Q3 24 | 16.8% | 64.1% | ||
| Q2 24 | 17.8% | 64.9% | ||
| Q1 24 | 8.8% | 61.4% |
营业利润率ESOAZLAB
| Q4 25 | 4.3% | -54.6% | ||
| Q3 25 | 5.8% | -42.3% | ||
| Q2 25 | 3.1% | -50.3% | ||
| Q1 25 | -10.6% | -53.3% | ||
| Q4 24 | 1.6% | -62.6% | ||
| Q3 24 | 8.4% | -66.6% | ||
| Q2 24 | 9.9% | -76.0% | ||
| Q1 24 | -1.5% | -80.7% |
净利率ESOAZLAB
| Q4 25 | — | — | ||
| Q3 25 | — | -31.2% | ||
| Q2 25 | — | -37.3% | ||
| Q1 25 | — | -45.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -40.9% | ||
| Q2 24 | — | -80.2% | ||
| Q1 24 | — | -61.4% |
每股收益（稀释后）ESOAZLAB
| Q4 25 | $0.16 | $-0.05 | ||
| Q3 25 | $0.26 | $-0.03 | ||
| Q2 25 | $0.12 | $-0.04 | ||
| Q1 25 | $-0.41 | $-0.04 | ||
| Q4 24 | $0.05 | $-0.09 | ||
| Q3 24 | $0.40 | $-0.04 | ||
| Q2 24 | $1.06 | $-0.08 | ||
| Q1 24 | $-0.07 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $16.7M | $689.6M |
| 总债务越低越好 | $62.0M | — |
| 股东权益账面价值 | $60.6M | $715.5M |
| 总资产 | $201.0M | $1.2B |
| 负债/权益比越低杠杆越低 | 1.02× | — |
8季度趋势，按日历期对齐
现金及短期投资ESOAZLAB
| Q4 25 | $16.7M | $689.6M | ||
| Q3 25 | $12.2M | $717.2M | ||
| Q2 25 | $15.3M | $732.2M | ||
| Q1 25 | $9.9M | $757.3M | ||
| Q4 24 | $20.3M | $779.7M | ||
| Q3 24 | $12.9M | $616.1M | ||
| Q2 24 | $14.5M | $630.0M | ||
| Q1 24 | $12.1M | $650.8M |
总债务ESOAZLAB
| Q4 25 | $62.0M | — | ||
| Q3 25 | $72.2M | — | ||
| Q2 25 | $59.1M | — | ||
| Q1 25 | $50.7M | — | ||
| Q4 24 | $59.6M | — | ||
| Q3 24 | $33.9M | — | ||
| Q2 24 | $31.9M | — | ||
| Q1 24 | $45.7M | — |
股东权益ESOAZLAB
| Q4 25 | $60.6M | $715.5M | ||
| Q3 25 | $59.2M | $759.9M | ||
| Q2 25 | $54.4M | $791.7M | ||
| Q1 25 | $53.7M | $810.8M | ||
| Q4 24 | $61.0M | $840.9M | ||
| Q3 24 | $58.7M | $667.7M | ||
| Q2 24 | $52.0M | $704.2M | ||
| Q1 24 | $34.6M | $762.2M |
总资产ESOAZLAB
| Q4 25 | $201.0M | $1.2B | ||
| Q3 25 | $215.2M | $1.2B | ||
| Q2 25 | $189.1M | $1.2B | ||
| Q1 25 | $170.2M | $1.2B | ||
| Q4 24 | $192.1M | $1.2B | ||
| Q3 24 | $158.2M | $985.3M | ||
| Q2 24 | $148.8M | $987.4M | ||
| Q1 24 | $136.1M | $988.4M |
负债/权益比ESOAZLAB
| Q4 25 | 1.02× | — | ||
| Q3 25 | 1.22× | — | ||
| Q2 25 | 1.09× | — | ||
| Q1 25 | 0.94× | — | ||
| Q4 24 | 0.98× | — | ||
| Q3 24 | 0.58× | — | ||
| Q2 24 | 0.61× | — | ||
| Q1 24 | 1.32× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.8M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $-26.7M |
| 自由现金流率自由现金流/营收 | 14.7% | -21.0% |
| 资本支出强度资本支出/营收 | 1.8% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $3.1M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流ESOAZLAB
| Q4 25 | $18.8M | $-26.0M | ||
| Q3 25 | $-9.3M | $-32.0M | ||
| Q2 25 | $3.4M | $-31.0M | ||
| Q1 25 | $1.1M | $-61.7M | ||
| Q4 24 | $8.9M | $-55.8M | ||
| Q3 24 | $-847.5K | $-26.8M | ||
| Q2 24 | $19.3M | $-42.2M | ||
| Q1 24 | $-2.7M | $-90.1M |
自由现金流ESOAZLAB
| Q4 25 | $16.8M | $-26.7M | ||
| Q3 25 | $-12.0M | $-35.0M | ||
| Q2 25 | $-582.0K | $-33.9M | ||
| Q1 25 | $-1.1M | $-63.2M | ||
| Q4 24 | $6.0M | $-58.4M | ||
| Q3 24 | $-2.9M | $-28.2M | ||
| Q2 24 | $16.3M | $-42.9M | ||
| Q1 24 | $-4.9M | $-91.1M |
自由现金流率ESOAZLAB
| Q4 25 | 14.7% | -21.0% | ||
| Q3 25 | -9.3% | -30.4% | ||
| Q2 25 | -0.6% | -31.1% | ||
| Q1 25 | -1.4% | -59.9% | ||
| Q4 24 | 5.9% | -53.8% | ||
| Q3 24 | -2.8% | -27.7% | ||
| Q2 24 | 18.9% | -42.9% | ||
| Q1 24 | -6.9% | -104.5% |
资本支出强度ESOAZLAB
| Q4 25 | 1.8% | 0.5% | ||
| Q3 25 | 2.1% | 2.6% | ||
| Q2 25 | 3.9% | 2.6% | ||
| Q1 25 | 2.9% | 1.5% | ||
| Q4 24 | 2.9% | 2.4% | ||
| Q3 24 | 2.0% | 1.3% | ||
| Q2 24 | 3.6% | 0.7% | ||
| Q1 24 | 3.1% | 1.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESOA
| Electricals Mechanical And General | $49.4M | 43% |
| Gas And Petroleum Transmission | $24.1M | 21% |
| Cost Plus And TM Contracts | $23.3M | 20% |
| Transferred At Point In Time | $17.9M | 16% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
